Patrick Muraca is picking up where he left off with Nuclea Biotechnologies.
The former CEO has started a new company and purchased the assets of the bankrupt Nuclea. NanoMolecular DX is now based out of Lee and is entering the commercial field with products developed under Nuclea, with many of the same investors, and some of the same employees.
PEDA is looking to recoup some $10,000 in losses from Nuclea Biotechnologies, Inc, which has filed for Chapter bankruptcy.
Nuclea had rented office space the from the Pittsfield Economic Development Authority on Kellogg Street for a number of years. That lease agreement was until the end of October this year.
Nuclea is closing its Pittsfield lab. The company announced "a major internal reorganization" on Monday that transfers its primary focus from research and development of products to commercialization. With that, the CLIA laboratory in Pittsfield will close.